Rep. Miller's Clinical Laboratory Price Transparency Act Included in Congressional Health Care Package
WASHINGTON, D.C. - Today, Congresswoman Carol Miller (R-WV) released the following statement on her Clinical Laboratory Price Transparency Act being included in the Lower Costs, More Transparency Act. This bill includes legislation that will provide patients with healthcare price transparency and lower costs across communities in the United States.
"Unknown health care prices should not be a factor that patients are worried about when making health care decisions," said Congresswoman Miller. "Patients should know their health care treatment prices upfront and not be surprised by sky-high bills they were unaware of. My Clinical Laboratory Price Transparency Act being included in the Lower Costs, More Transparency Act will allow clinical labs to publish their prices upfront, so patients are given the opportunity to make wise health care decisions. I am looking forward to the passage of this bill on the House of Representatives floor which will put our patients first.”
“Too often, American families are unable to obtain up-front price information for basic procedures like blood draws and tests,” said Ways and Means Committee Chairman Jason Smith (MO-08). “I want to thank Rep. Miller for her leadership in introducing the Clinical Laboratory Price Transparency Act that will empower patients to comparison shop for affordable, quality lab work in their community.”
The Lower Costs, More Transparency Act is introduced by House Ways and Means Committee Chair Jason Smith (R-MO), House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Ranking Member Frank Pallone, Jr. (D-NJ), and House Education and the Workforce Chair Virginia Foxx (R-NC).
Click here for bill text of the Lower Costs, More Transparency Act.
Background:
- The Clinical Laboratory Price Transparency Act will require labs, effective January 1, 2025, under Medicare to publish their health care prices, require CMS to provide standard reporting formats for providers to use, and ensure CMS specifies the services to which transparency will apply while monitoring compliance.